HRTX icon

Heron Therapeutics

174 hedge funds and large institutions have $321M invested in Heron Therapeutics in 2022 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 57 increasing their positions, 55 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more ownership

Funds ownership:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding:

35% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 26

48% less capital invested

Capital invested by funds: $621M → $321M (-$299M)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
174
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.19M
Puts
$232K
Net Calls
Net Calls Change

Top Buyers

1 +$28.3M
2 +$9.5M
3 +$2.35M
4
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
+$2.12M
5
BlackRock
BlackRock
New York
+$1.78M

Top Sellers

1 -$20.1M
2 -$5.5M
3 -$3.64M
4
Goldman Sachs
Goldman Sachs
New York
-$2.8M
5
Millennium Management
Millennium Management
New York
-$2.71M
Name Holding Trade Value Shares
Change
Change in
Stake
51
$445K
52
$407K
53
$391K
54
$385K
55
$369K
56
$364K
57
$363K
58
$337K
59
$328K
60
$309K
61
$299K
62
$268K
63
$260K
64
$242K
65
$225K
66
$221K
67
$218K
68
$208K
69
$191K
70
$189K
71
$182K
72
$170K
73
$163K
74
$160K
75
$154K